Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2

IND filing today for STI-1499 (COVI-GUARD™) for hospitalized COVID-19 patients. The initial trial is expected to…

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex

– Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –…

ALERT COVID-19 | Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3

RVV | RVVTF TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the…

Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

Algernon Pharmaceuticals Inc. (CSE: AGN) VANCOUVER, British Columbia, April 22, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE:…

WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences

WPD Pharmaceuticals Inc. (CSE: WBIO) VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE:…

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) Kelowna, British Columbia – TheNewswire – April 21, 2020 – Lexaria Bioscience Corp. (OTC:LXRP)…

ImmunoPrecise Provides Updates on B Cell Select™ and Deep Display™ Programs for SARS-CoV-2 Antibody Discovery

VICTORIA, April 17, 2020 /CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC QB:…

PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial

Expanded infectious disease program to address current and potential pandemics builds on existing tuberculosis collaboration Initiation…

ImmunoPrecise Participates in Public Consensus Statement, from the WHO, on Collaboration for Developing a COVID-19 Vaccine

VICTORIA, April 15, 2020 /CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC QB:…

Generex Biotechnology Provides Update on the Development of an Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic

Working with a team of corporate collaborators, academic advisors, and contract manufacturers to prepare contract proposals…

UPDATE – BriaCell Files Coronavirus Immunotherapy Patent

BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) BERKELEY, Calif. and VANCOUVER, British Columbia, April 14, 2020 (GLOBE NEWSWIRE)…

VAXIL PROVIDES UPDATE ON PRECLINICAL EXPERIMENT

VAXIL BIO LTD. (TSX VENTURE: VXL) VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL),…